Esketamine based antidepressant treatment has passed yet another drug trial, but who should expect to be prescribed this fast-acting treatment.
Share to linkedin
Depression is a widespread disorder affecting around 300 million people globally. Having a treatment for those who failed to respond to previous courses of action could mean these patients would be able to return to work, interact with their families and more importantly regain the functionality they lost to their illness.
Even in patients without suicidal intent, depression is unpleasant to say the absolute least. That being said, if SPRAVATO acts so fast, why not offer it to all patients? It doesn’t quite work like that.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ketamine Depression Treatment Passes Another Trial, But Isn’t For EveryoneEsketamine based antidepressant treatment has passed yet another drug trial, but who should expect to be prescribed this fast-acting treatment.
Read more »
Fake Meat Fight: Can The Plant-Based Movement Get Past The ‘Processed Food’ Debate?Unlike Impossible Foods, which gets its beefy taste from genetically engineered yeast, Beyond embraced the non-GMO label in hopes of straddling the nature-tech divide. The move failed to win over critics but critics may have missed the mark too. Can the plant-based movement get past this debate?
Read more »
My Airpod Case Is Currently The Most Complimented Piece I OwnEveryone loves it, from fashion editors to strangers at Popeye's.
Read more »
Children and FluWebMD goes over the causes, symptoms, and treatments of a child’s flu.
Read more »